Cargando…

Enhancing Endocannabinoid Control of Stress with Cannabidiol

The stress response is a well-defined physiological function activated frequently by life events. However, sometimes the stress response can be inappropriate, excessive, or prolonged; in which case, it can hinder rather than help in coping with the stressor, impair normal functioning, and increase t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Henson, Jeremy D., Vitetta, Luis, Quezada, Michelle, Hall, Sean
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704602/ https://www.ncbi.nlm.nih.gov/pubmed/34945148 http://dx.doi.org/10.3390/jcm10245852

Ejemplares similares

Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions
por: Henson, Jeremy D., et al.
Publicado: (2022)

Intestinal Dysbiosis, the Tryptophan Pathway and Nonalcoholic Steatohepatitis
por: Chen, Jiezhong, et al.
Publicado: (2022)

Pilot clinical and pharmacokinetic study of Δ(9)-Tetrahydrocannabinol (THC)/Cannabidiol (CBD) nanoparticle oro-buccal spray in patients with advanced cancer experiencing uncontrolled pain
por: Clarke, Stephen, et al.
Publicado: (2022)

The Endocannabinoid System and Cannabidiol: Past, Present, and Prospective for Cardiovascular Diseases
por: Rabino, Martina, et al.
Publicado: (2021)

The endocannabinoid system, cannabis, and cannabidiol: Implications in urology and men's health
por: Capodice, Jillian L., et al.
Publicado: (2021)

Translating Endocannabinoid Biology into Clinical Practice: Cannabidiol for Stroke Prevention
por: Scharf, Eugene L.
Publicado: (2017)

The intestinal microbiota and improving the efficacy of COVID-19 vaccinations
por: Chen, Jiezhong, et al.
Publicado: (2021)

Prebiotics Progress Shifts in the Intestinal Microbiome That Benefits Patients with Type 2 Diabetes Mellitus
por: Vitetta, Luis, et al.
Publicado: (2023)

The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder
por: Chye, Yann, et al.
Publicado: (2019)

Role of the endocannabinoid system in fragile X syndrome: potential mechanisms for benefit from cannabidiol treatment
por: Palumbo, Joseph M., et al.
Publicado: (2023)

Adjuvant Probiotics and the Intestinal Microbiome: Enhancing Vaccines and Immunotherapy Outcomes
por: Vitetta, Luis, et al.
Publicado: (2017)

Oxyradical Stress, Endocannabinoids, and Atherosclerosis
por: Matthews, Anberitha T., et al.
Publicado: (2015)

Metabolic Interactions in the Gastrointestinal Tract (GIT): Host, Commensal, Probiotics, and Bacteriophage Influences
por: Vitetta, Luis, et al.
Publicado: (2015)

Endocannabinoids in Body Weight Control
por: Horn, Henrike, et al.
Publicado: (2018)

The Brain–Intestinal Mucosa–Appendix– Microbiome–Brain Loop
por: Vitetta, Luis, et al.
Publicado: (2018)

Immunological Tolerance and Function: Associations Between Intestinal Bacteria, Probiotics, Prebiotics, and Phages
por: Vitetta, Luis, et al.
Publicado: (2018)

Vasoprotective Endothelial Effects of Chronic Cannabidiol Treatment and Its Influence on the Endocannabinoid System in Rats with Primary and Secondary Hypertension
por: Baranowska-Kuczko, Marta, et al.
Publicado: (2021)

Endocannabinoids and Schizophrenia
por: Desfossés, Joëlle, et al.
Publicado: (2010)

Endocannabinoids and Immunity
por: Chiurchiù, Valerio
Publicado: (2016)

Endocannabinoids in the Gut
por: DiPatrizio, Nicholas V.
Publicado: (2016)

Perna canaliculus and the Intestinal Microbiome
por: Saltzman, Emma Tali, et al.
Publicado: (2017)

Interacting binding insights and conformational consequences of the differential activity of cannabidiol with two endocannabinoid-activated G-protein-coupled receptors
por: Dávila, Eliud Morales, et al.
Publicado: (2022)

The Epigenetics of the Endocannabinoid System
por: Meccariello, Rosaria, et al.
Publicado: (2020)

A urinary test procedure for identification of cannabidiol in patients undergoing medical therapy with marijuana
por: Wertlake, Paul T, et al.
Publicado: (2016)

Modulation of the Oxidative Stress and Lipid Peroxidation by Endocannabinoids and Their Lipid Analogues
por: Gallelli, Cristina Anna, et al.
Publicado: (2018)

Endocannabinoids as Guardians of Metastasis
por: Tegeder, Irmgard
Publicado: (2016)

The Endocannabinoid System of Animals
por: Silver, Robert J.
Publicado: (2019)

Endocannabinoid System in the Airways
por: Bozkurt, Turgut Emrah
Publicado: (2019)

Modulating the Gut Micro-Environment in the Treatment of Intestinal Parasites
por: Vitetta, Luis, et al.
Publicado: (2016)

Endocannabinoids and the Gut-Brain Control of Food Intake and Obesity
por: DiPatrizio, Nicholas V.
Publicado: (2021)

Control of synaptic function by endocannabinoid-mediated retrograde signaling
por: KANO, Masanobu
Publicado: (2014)

A Double-Blind Randomized Placebo-Controlled Study Assessing the Safety, Tolerability and Efficacy of a Herbal Medicine Containing Pycnogenol Combined with Papain and Aloe vera in the Prevention and Management of Pre-Diabetes
por: Vitetta, Luis, et al.
Publicado: (2020)

Motion Sickness, Stress and the Endocannabinoid System
por: Choukèr, Alexander, et al.
Publicado: (2010)

The Polypharmacological Effects of Cannabidiol
por: Castillo-Arellano, Jorge, et al.
Publicado: (2023)

Correction: Vitetta, L.; et al. Adjuvant Probiotics and the Intestinal Microbiome: Enhancing Vaccines and Immunotherapy Outcomes. Vaccines 2017, 5, 50
por: Vitetta, Luis, et al.
Publicado: (2018)

Translational evidence for the involvement of the endocannabinoid system in stress-related psychiatric illnesses
por: Hill, Matthew N, et al.
Publicado: (2013)

Endocannabinoid-Epigenetic Cross-Talk: A Bridge toward Stress Coping
por: Rusconi, Francesco, et al.
Publicado: (2020)

Cannabidiol modulation of oxidative stress and signalling
por: Pereira, Sónia R., et al.
Publicado: (2021)

Chronic Cannabidiol Administration Fails to Diminish Blood Pressure in Rats with Primary and Secondary Hypertension Despite Its Effects on Cardiac and Plasma Endocannabinoid System, Oxidative Stress and Lipid Metabolism
por: Remiszewski, Patryk, et al.
Publicado: (2020)

The endocannabinoid system: ‘NO’ longer anonymous in the control of nitrergic signalling?
por: Lipina, Christopher, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_orp12q9am5fr896g72sjeobr49